Artemisia atrovirens
What's the taxonomical classification of Artemisia atrovirens?
Artemisia atrovirens belongs to the kingdom Plantae and is classified within the phylum Streptophyta. It falls under the class Equisetopsida and the subclass Magnoliidae, following the taxonomic order Asterales. As a member of the prominent family Asteraceae, this plant is situated within the genus Artemisia, ultimately reaching its specific identification as the species atrovirens.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Artemisia |
| Species | atrovirens |
What are the morphological characteristics of this plant?
Artemisia atrovirens has a perennial growth habit characterized by erect, woody stems and deeply pinnatifid leaves that exhibit a distinct dark green to grayish-green coloration. The foliage is highly dissected, often featuring narrow, linear lobes that give the plant a feathery appearance. Its leaves are typically covered in fine hairs, which contributes to a subtle pubescence across the surface. During the flowering season, the plant produces small, inconspicuous flower heads arranged in dense, terminal clusters. These inflorescences are characteristic of the genus and are often surrounded by specialized bracts.
What is the geographical distribution of this plant?
This plant is endemic to the high-altitude regions of the Tibetan Plateau, specifically within the Xinjiang and Qinghai provinces of China. It thrives in alpine environments characterized by rocky slopes and arid montane habitats. Its presence is typically restricted to specific elevational zones where the climate remains cold and dry. The species occupies niche ecological pockets that favor its unique physiological adaptations to extreme mountain conditions. This localized distribution makes it a specialized component of the high-altitude Central Asian flora.
How is this plant cultivated?
This plant requires well-drained, sandy or gravelly soil and full sun exposure to thrive in a garden setting.
You should sow the seeds in early spring or late autumn to ensure successful germination. Once established, the plant is highly drought-tolerant and necessitates minimal supplemental watering. Regular pruning can help maintain its compact shape and prevent the stems from becoming too woody.
Avoid overwatering or planting in heavy clay, as this can lead to root rot.
What parts of this plant are used medicinally?
Artemisia atrovirens contains bioactive compounds primarily located within its aerial parts, specifically the leaves and flowering stems. These vegetative structures are harvested to extract essential oils and secondary metabolites used in traditional remedies. The leaves are often prepared as infusions or decoctions to address various ailments. Some applications involve using the crushed foliage for topical treatments due to its chemical properties. Researchers study these specific components to understand their potential pharmacological effects on human health.
What traditional systems uses this plant?
This plant, Artemisia atrovirens, has been traditionally utilized in various indigenous medicinal practices across parts of Africa and arid regions for treating stomach ailments and digestive disorders.
Local healers often prepare infusions or decoctions from the leaves to alleviate intestinal discomfort and parasitic infections. Historical records suggest that the plant's bitter properties were valued for stimulating appetite and aiding overall metabolic function. In some specific cultural contexts, it has also been applied topically to address skin irritations or minor wounds.
These long-standing customary uses highlight the plant's significance within the ethnobotanical knowledge of the communities where it grows naturally.
What are the pharmacological activities of Artemisia atrovirens?
This plant has demonstrated significant pharmacological activities including anti-cervical cancer, antihepatoma, and cytotoxic effects. Research indicates that its chemical constituents possess potent cytotoxicity against various malignant cell lines. Specifically, the extract shows promise in inhibiting the growth of cervical cancer cells. It also exhibits notable antihepatoma activity by targeting liver cancer cell proliferation. These biological properties highlight its potential role in developing new therapeutic agents for oncology.
According to a study published by "Phytomedicine : international journal of phytotherapy and phytopharmacology", the guaianolide dimer artematrolide A (AR-A) isolated from Artemisia atrovirens demonstrated significant inhibitory effects on 3 human hepatoma cell lines, specifically HepG2, Huh7 and SMMC7721. When HeLa S3 and SiHa cells were treated with artematrolide A, the compound inhibited cell viability, proliferation, migration and invasion in a dose-dependent manner. It induced cell apoptosis via Bcl-2/PARP-1 and caused cell cycle arrest in the G2/M phase. The mechanism of action involved suppressing proliferation by activating the ROS/ERK/mTOR signaling pathway. Furthermore, it promoted a metabolic shift from aerobic glycolysis to mitochondrial respiration by activating the pyruvate dehydrogenase complex (PDC) and oxoglutarate dehydrogenase complex (OGDC) through the inhibition of alkaline phosphatases (ALP) activity.
The primary pharmacological activities of this plant are shown in the list below.
- anti-cervical cancer
- antihepatoma activity
- cytotoxic
- cytotoxicity
What medicinal compounds this plant contains?
This plant contains several specific medicinal compounds including Artatrovirenol A, Artatrovirenol B, Artematrolide A, Artematrovirenins A-P, and seco-atrovirenolide A. These chemical constituents are primarily classified as specialized secondary metabolites derived from the Artemisia genus. Researchers study these particular molecules to understand their potential bioactive properties and therapeutic applications. The presence of these diverse sesquiterpene lactones contributes to the complex chemical profile of the species. Detailed phytochemical analysis is required to isolate and characterize each individual derivative for pharmacological testing.
According to a study published by "The Journal of organic chemistry", Artemisia atrovirens contains two novel cagelike sesquiterpenoids known as artatrovirenols A and B. These compounds, identified as 1 and 2, possess a unique 5/5/6/5/5-pentacyclic and a 5/5/6/5-tetracyclic system featuring an unprecedented tetracyclo[5.3.1.1.4,11 0,1,5]dodecane scaffold. Compound 1 demonstrated cytotoxicity against 3 human hepatoma cell lines, which included HepG2, SMMC-7721, and Huh7. The half maximal inhibitory concentration values for these cell lines were 123.8, 44.0, and 142.6 μM, respectively. These new isolates were proposed to originate from the naturally occurring arglabin, labeled as 3.
The primary medicinal compounds of this plant are shown in the list below.
- Artatrovirenol A
- Artatrovirenol B
- Artematrolide A
- Artematrovirenins A-P
- seco-atrovirenolide A
What health conditions is this plant used for?
This plant is used for the treatment and management of cervical cancer and hepatoma. Research suggests that its bioactive compounds may inhibit the growth of these specific malignant tumors. The medicinal properties of Artemisia atrovirides are often studied for their potential to induce apoptosis in cancer cells. These therapeutic effects are believed to stem from the plant's complex chemical profile. Ongoing studies continue to investigate how these extracts can be effectively integrated into oncology treatments.
According to a study published by "Phytomedicine : international journal of phytotherapy and phytopharmacology", the guaianolide dimer artematrolide A isolated from Artemisia atrovirens demonstrated significant inhibitory effects on 3 human hepatoma cell lines including HepG2, Huh7 and SMMC7721. This compound was also evaluated for its potential as a treatment for cervical cancer by treating HeLa S3 and SiHa cells at various concentrations. Artematrolide A inhibited cell viability, proliferation, migration and invasion in a dose-dependent manner. The substance induced cell apoptosis via Bcl-2/PARP-1 and caused cell cycle arrest specifically in the G2/M phase. By inhibiting the activity of alkaline phosphatases, it promotes a metabolic shift from aerobic glycolysis to mitochondrial respiration.
The main health conditions this plant is used for are shown in the list below.
- cervical cancer
- hepatoma
What are the herbal preparations of this plant?
This plant is Artemisia atrovirides, which is utilized to create medicinal herbal preparations such as EtOH extract and fine powder. Researchers often employ ethanol to extract bioactive compounds from the plant material for concentrated therapeutic use. The resulting EtOH extract provides a potent form of the plant's chemical constituents for pharmacological study. Additionally, the dried plant can be processed into a standardized powder for various traditional applications. These distinct preparations allow for different methods of administration and varying levels of potency.
According to a study published by "Bioorganic chemistry", the EtOH extract of Artemisia atrovirens demonstrated significant cytotoxicity against two human hepatoma cell lines, HepG2 and Huh7, with inhibitory ratios of 98.9% and 99.7% at a concentration of 100 μg/mL. Bioactivity-guided isolation of the active fraction resulted in 16 new guaiane-type sesquiterpenoids named artematrovirenins A-P (1-16). Among these, five compounds (3, 5, 8, 10, and 15) exhibited cytotoxicity. Specifically, compounds 3 and 5 displayed cytotoxicity against the HepG2 cell line with IC50 values of 8.0 and 16.0 μM, respectively. Additionally, compounds 3 and 5 showed cytotoxicity against the Huh7 cell line with values of 18.2 and 32.2 μM.
The main herbal preparations of this plant are shown in the list below.
- EtOH extract
- powder
What side effects this plant can have?
This plant can cause gastrointestinal distress, skin irritation, and potential neurotoxicity if consumed in large quantities. The chemical compounds within its leaves may trigger allergic reactions or contact dermatitis in sensitive individuals. Some studies suggest that certain alkaloids present in the plant could interfere with neurological functions. Prolonged exposure or ingestion may also lead to unexpected metabolic disruptions. Users should exercise extreme caution to avoid these adverse physiological responses.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Artemisia atrovirens?
This plant pairs effectively with culinary and medicinal herbs such as sage, rosemary, and thyme to enhance its complex aromatic profile.
The woody undertones of Artemisia atrovirides complement the earthy notes found in sage, creating a balanced herbal blend. When used in aromatic infusions, it integrates well with the sharp, pine-like scent of rosemary. These combinations are often explored in traditional botanical preparations to create nuanced scent profiles.
Adding thyme provides a subtle floral layer that bridges the gap between the plant's bitter edges and its warmer companions.